https://www.zacks.com/stock/news/2237550/abbott-abt-to-reduce-childhood-malnutrition-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2237550
Mar 07, 2024 - Abbott's (ABT) latest partnership supports its sustainability goal of transforming care for malnutrition and improving the lives of 3 billion people per year by the decade's end.
zc:1815782283625796570
0
https://www.zacks.com/commentary/2230125/top-analyst-reports-for-microsoft-amazon-com-berkshire-hathaway?cid=CS-ZC-FT-research_daily-2230125
Feb 22, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Amazon.com, Inc. (AMZN) and Berkshire Hathaway Inc. (BRK.B).
zc:-5283778767734344972
0
https://www.zacks.com/stock/news/2223400/insulet-s-podd-omnipod-5-gets-ce-mark-for-added-compatibility?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2223400
Feb 08, 2024 - Insulet's (PODD) tubeless automated insulin delivery system's CE mark approval with multiple CGM sensor brands is likely to serve a wider patient pool.
zc:89074066058564723
0
https://www.zacks.com/stock/news/2221954/hae-vs-abt-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2221954
Feb 06, 2024 - HAE vs. ABT: Which Stock Is the Better Value Option?
zc:5368276042455414892
0
https://www.zacks.com/commentary/2219543/top-research-reports-for-abbott-t-mobile-booking?cid=CS-ZC-FT-research_daily-2219543
Feb 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).
zc:-2929895383254301058
0
https://www.fool.com/earnings/call-transcripts/2024/01/24/abbott-laboratories-abt-q4-2023-earnings-call-tran/?source=iedfolrf0000001
Jan 24, 2024 - ABT earnings call for the period ending December 31, 2023.
0
fool:-5809030648068717040
0
https://www.zacks.com/stock/news/2215065/q4-earnings-roundup-abt-gd-kmb-more?cid=CS-ZC-FT-ahead_of_wall_street-2215065
Jan 24, 2024 - A spot-check of early morning Q4 reports show some earnings misses and revenue beats; Tesla and others report after the close.
zc:-1549680932567244275
0
https://www.zacks.com/stock/news/2213563/what-s-in-store-for-zimmer-biomet-zbh-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213563
Jan 22, 2024 - Zimmer Biomet (ZBH) is expected to have gained from the uptake of Persona OsseoTi Keel Tibia for Cementless Knee Replacement in the fourth quarter.
zc:8003005064229493104
0
https://www.zacks.com/stock/news/2213031/seeking-clues-to-abbott-abt-q4-earnings-a-peek-into-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2213031
Jan 19, 2024 - Beyond analysts' top -and-bottom-line estimates for Abbott (ABT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
zc:-3963851460063258457
0
https://www.zacks.com/stock/news/2212321/will-abbott-abt-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2212321
Jan 18, 2024 - Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:-5656202813744707171
0